"#3: RecurIndex assay as an aid for adjuvant chemotherapy decisions in HR-positive HER2-negative breast cancer patients 👩⚕️👨⚕️ Haibo Wang et al Read now 👉 https://t.co/paQfNuVpYO #Oncology"
6,540 followers
17,731 followers
RecurIndex assay as an aid for adjuvant chemotherapy decisions in HR-positive HER2-negative breast cancer patients https://t.co/sSTnkl6g5F https://t.co/eHVGtnllwo
6,540 followers
New research: RecurIndex assay as an aid for adjuvant chemotherapy decisions in HR-positive HER2-negative breast cancer patients: Background Adjuvant chemotherapy is a major adjuvant treatment modality for hormonal receptor (HR)-positive and… https://t.co